These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16046527)
1. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Menu E; Jernberg-Wiklund H; Stromberg T; De Raeve H; Girnita L; Larsson O; Axelson M; Asosingh K; Nilsson K; Van Camp B; Vanderkerken K Blood; 2006 Jan; 107(2):655-60. PubMed ID: 16046527 [TBL] [Abstract][Full Text] [Related]
2. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681 [TBL] [Abstract][Full Text] [Related]
5. Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival. Menu E; Jernberg-Wiklund H; De Raeve H; De Leenheer E; Coulton L; Gallagher O; Van Valckenborgh E; Larsson O; Axelson M; Nilsson K; Van Camp B; Croucher P; Vanderkerken K Int J Cancer; 2007 Oct; 121(8):1857-61. PubMed ID: 17546599 [TBL] [Abstract][Full Text] [Related]
6. The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllin. Lemaire M; Fristedt C; Agarwal P; Menu E; Van Valckenborgh E; De Bruyne E; Österborg A; Atadja P; Larsson O; Axelson M; Van Camp B; Jernberg-Wiklund H; Vanderkerken K Clin Cancer Res; 2012 Apr; 18(8):2230-9. PubMed ID: 22392915 [TBL] [Abstract][Full Text] [Related]
7. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling. Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin. Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930 [TBL] [Abstract][Full Text] [Related]
9. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model. Yin SC; Guo W; Tao ZZ Biochem Biophys Res Commun; 2013 Sep; 439(1):1-5. PubMed ID: 23973483 [TBL] [Abstract][Full Text] [Related]
10. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Menu E; Kooijman R; Van Valckenborgh E; Asosingh K; Bakkus M; Van Camp B; Vanderkerken K Br J Cancer; 2004 Mar; 90(5):1076-83. PubMed ID: 14997210 [TBL] [Abstract][Full Text] [Related]
11. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Vasilcanu D; Girnita A; Girnita L; Vasilcanu R; Axelson M; Larsson O Oncogene; 2004 Oct; 23(47):7854-62. PubMed ID: 15334055 [TBL] [Abstract][Full Text] [Related]
12. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin. Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354 [TBL] [Abstract][Full Text] [Related]
13. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470 [TBL] [Abstract][Full Text] [Related]
14. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2337-42. PubMed ID: 18515579 [TBL] [Abstract][Full Text] [Related]
15. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1. Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296 [TBL] [Abstract][Full Text] [Related]
16. The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic. Bieghs L; Lub S; Fostier K; Maes K; Van Valckenborgh E; Menu E; Johnsen HE; Overgaard MT; Larsson O; Axelson M; Nyegaard M; Schots R; Jernberg-Wiklund H; Vanderkerken K; De Bruyne E Oncotarget; 2014 Nov; 5(22):11193-208. PubMed ID: 25008202 [TBL] [Abstract][Full Text] [Related]
17. Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention. Zhang Q; Pan J; Lubet RA; Wang Y; You M Mol Carcinog; 2015 Jun; 54 Suppl 1():E129-37. PubMed ID: 25163779 [TBL] [Abstract][Full Text] [Related]
18. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O Acta Ophthalmol; 2008 Nov; 86 Thesis 4():35-41. PubMed ID: 19032680 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450 [TBL] [Abstract][Full Text] [Related]
20. Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo. Tarnowski M; Tkacz M; Zgutka K; Bujak J; Kopytko P; Pawlik A BMC Cancer; 2017 Aug; 17(1):532. PubMed ID: 28793874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]